Physician profile
Anelyn Robaina
NPI 1962991463
$630.50
in general payments reported to CMS, 2019-2025
8 companies · $39.71 in 2025
The $39.71 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.35 · 2022: $96.71 · 2023: $290 · 2024: $166 · 2025: $39.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $178.02 | 2022-2025 | Andexxa, Wainua |
| Stryker Corporation | $148.10 | 2023 | Everest Spinal System |
| Pfizer INC. | $90.43 | 2023-2024 | |
| Medtronic, INC. | $65.13 | 2024-2025 | Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $64.76 | 2022 | |
| Ucb, INC. | $38.35 | 2021 | |
| Omniscient Neurotechnology America LTD | $30.22 | 2023 | Quicktome |
| Insightec,INC | $15.49 | 2023 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anelyn Robaina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.